Rhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts

    NEXT STORY
    TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review
    PREV STORY
    PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    G1 Therapeutics to Report Myelopreservation Data from Randomized Phase 2 Trial of Trilaciclib/Chemotherapy/Tecentriq® in Small Cell Lung Cancer in Fourth Quarter 2018

    Management to host webcast and conference call today at 8:30 a.m. ETRESEARCH TRIANGLE PARK, ...

    author_avatar
    NASDAQ Market News

    Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

    author_avatar
    NASDAQ Market News

    Novartis delivered growth on top and bottom line in all divisions in Q3

    Net sales grew 2% (cc[1], +2% USD), with growth in all divisions: Cosentyx (USD ...

    author_avatar
    NASDAQ Market News